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Abstract
Abnormal mitochondrial function is a widely reported contributor to neurodegenerative disease including Alzheimer’s
disease (AD), however, a mechanistic link between mitochondrial dysfunction and the initiation of neuropathology remains
elusive. In AD, one of the earliest hallmark pathologies is neuropil threads comprising accumulated hyperphosphorylated
microtubule-associated protein (MAP) tau in neurites. Rod-like aggregates of actin and its associated protein cofilin (AC
rods) also occur in AD. Using a series of antibodies - AT270, AT8, AT100, S214, AT180, 12E8, S396, S404 and S422 - raised
against different phosphoepitopes on tau, we characterize the pattern of expression and re-distribution in neurites of these
phosphoepitope labels during mitochondrial inhibition. Employing chick primary neuron cultures, we demonstrate that
epitopes recognized by the monoclonal antibody 12E8, are the only species rapidly recruited into AC rods. These results
were recapitulated with the actin depolymerizing drug Latrunculin B, which induces AC rods and a concomitant increase in
the 12E8 signal measured on Western blot. This suggests that AC rods may be one way in which MAP redistribution and
phosphorylation is influenced in neurons during mitochondrial stress and potentially in the early pathogenesis of AD.
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Introduction
Neuronal histopathological hallmarks of AD include neurofi-
brillary tangles (NFT) and neuropil threads both comprised of
hyperphosphorylated microtubule-associated protein (MAP) tau.
NFTs and neuropil threads assemble in cell bodies and neurites
respectively. Comprising a reported .85% of end-stage cortical
tau pathology, neuropil threads correlate with cognitive decline
[1–6]. The major known function of tau, like other MAPs, is its
stabilization and regulation of microtubule (MT) dynamics
necessary for neurite outgrowth, morphogenesis and since tau is
predominantly an axonal protein, it plays an important role in
facilitating MT-dependent axonal transport (for reviews see [7,8]).
Tau can also interact with the plasma membrane and may play
roles in relaying signals to the cytoskeleton from the cell surface or
scaffolding signaling complexes [9]. The MT directed activity of
tau is regulated by phosphorylation/dephosphorylation cycles,
such that phosphorylation at specific sites detaches tau from MTs
and allows MT depolymerization, while tau dephosphorylation
enables it to bind and stabilize MT via its MT binding domain
(MTBD) [10,11]. In AD, tau is hyperphosphorylated, the MT
network is destabilized and tau self-assembles into paired helical
filaments (PHFs) that form the NFT and neuropil thread
structures. Over 20 phosphorylation sites have been characterized
for tau, two of these are located in the MTBD at two ‘KXGS’
amino acid motifs corresponding to residues S262 and S356 [11–
13]. Phosphorylation of these KXGS motifs is one of the earliest
markers of AD pathology, readily detectable in neuropil threads
with the monoclonal antibody 12E8 that recognizes these
conserved motifs in both tau as well as in other MAPs [14]. In
the case of tau, phosphorylation of the MTBD sites has been
shown to induce MT disassembly whereby the new unbound pool
of tau is susceptible to self-assembly into PHFs [12,15–17].
Neuropil threads generally precede the appearance of extensive
NFTs, suggesting tau first accumulates in neurites during the
development of AD pathology before the proliferation of cell body
NFTs [1,4,18,19]. An in vitro cell model for neuropil thread
assembly may therefore help mimic early cellular events relevant
to the disease mechanism. To this end, we recently demonstrated
in primary neuronal cell culture and organotypic slice culture that
mitochondrial dysfunction initiates formation of 12E8-positive
neuritic inclusions that co-localize with actin depolymerizing
factor (ADF)/cofilin-actin rods (AC rods) [20]. These inclusions
bear some morphological resemblance to inclusions observed in
AD brain which also include punctuate and rod-like linear arrays
of cofilin and actin aggregates throughout the neuropil [21]
(reviewed in [22]). The relevance of this model lies in an increasing
body of evidence that implicates disrupted energy metabolism and
mitochondrial dysfunction in AD (for reviews see [23–27]).
Reduced mitochondrial function and increased oxidative stress
are reported to occur early in disease progression, suggesting that
these factors could play an integral role in initiating pathological
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rods are independently induced in cell culture by the inhibition of
mitochondrial ATP generation, thus potentially linking the
formation and co-localization of AC rods and MAP inclusions to
mitochondrial dysfunction [20]. Moreover, interaction of MAPs
and actin in the organization of the cytoskeletal network is well-
documented [28–35] and emerging evidence suggests that these
interactions may be central to the processes involved in the
initiation and development of early AD pathology [20,22,36,37].
Since AD neuropathology involves hyperphosphorylation and
accumulation of numerous phosphoepitopes of tau and not just
those in the MTBD recognized by 12E8, the aim of this study was
to investigate the phosphorylation pattern and re-distribution of
several other key phospho-tau epitopes in the primary neuronal
culture model. We utilized the chick model since chick neurons
express five forms of tau that are homologous to human tau
isoforms and exhibit conserved phosphoepitopes recognized by
antibodies against human tau [38]. Using a series of commercially
available phospho-tau antibodies, we measured time-dependent
effects of mitochondrial dysfunction on the levels and distribution
patterns of these phosphoepitopes. We found that cellular ATP
reduction gave rise to rapid overall dephosphorylation at most
epitopes with the exception of the 12E8 epitope that exhibited
persistent phosphorylation over the 120 min treatment time.
Further, 12E8 was the only epitope predominantly recruited to
AC rods generated under these conditions within the time frame
investigated. These results highlight the MTBD of MAP/tau as a
potential early player in the initiation of neuropil threads in
neurons of the AD brain.
Methods
Ethics Statement
Donated frontal cortex and hippocampal brain tissue from
normal adult and confirmed Alzheimer’s disease patients were
obtained from the Alzheimer Disease Research Center, University
of California, San Diego, USA and approved for use by the
Institutional Review Board (formerly the Human Research
Committee), Colorado State University, USA (Approval ID: JR
Bamburg 2001).
Experiments involving the use of animals (cell cultures derived
from chicken embryos) were approved by the Animal Ethics
Committee, University of Sydney, Australia (Approval ID: CS
Goldsbury K00/5-2008/3/4786).
Antibodies and reagents
Mouse monoclonal antibodies against phosphorylated tau epitopes
were as follows: AT8 (which recognizes S202/T205 in the longest
isoform of human tau and S193/T196 in the longest isoform of chick
tau; Pierce USA), AT100 (T212/S214 in human, T203/S205 in chick;
Sigma-Aldrich), AT180 (T231/S235 in human, T222/S226 in chick;
Sigma-Aldrich), AT270 (T181 in human, T155 in chick; Sigma-
Aldrich), 12E8 (‘KXGS’ motifs in MTBDs of tau and other MAPs. For
tau, these motifs correspond to S262/S356 in human, S253/S378 in
chick; Elan USA) [14]. Other mouse monoclonal antibodies included
GAPDH and b-actin (Sigma-Aldrich). Rabbit polyclonal antibodies
against phosphorylated tau epitopes were S214 (S205 in chick;
GenScript USA), S396 (S418 in chick; Biosource), S404 (S426 in chick;
Biosource), S422 (S444 in chick; Sigma-Aldrich), total tau (Dako, USA)
and against chick ADF and mammalian ADF and cofilin (1439) [39].
Anti-mouse and anti-rabbit secondary antibodies included Alexa
Fluor-conjugated 488, 555, 594 and 647 (Invitrogen) for immunoflu-
orescence and horseradish peroxidase-conjugated (Amersham) for
chemiluminescence detection of immunoblots.
Cell culture and treatments
Primary chick tectal neurons were prepared from freshly
dissected chicken embryos (E7), as previously described and
cultured for 7 days in vitro (d.i.v) on poly-D-lysine-coated 30 mm
culture dishes or glass coverslips [40]. For reduction of ATP, cells
were treated with 1–2 mM antimycin (AM; a mitochondrial
complex III inhibitor; Sigma-Aldrich) in warm phosphate buffered
saline (PBS). The actin depolymerizing drug Latrunculin B
(Calbiochem 428020, CA) and actin stabilizing drug Jasplakinolide
(Calbiochem 420127, CA) were used at 1 mg/ml in warm PBS.
Cells left without a medium change served as controls. After
treatments, cells were immediately fixed for immunostaining (cells
on coverslips) or lysed, harvested and prepared for Western blot
analysis (cells on tissue culture dishes).
Immunoblotting
Primary neurons were treated in duplicate and prepared for
SDS-PAGE. For equal gel loading, protein concentrations were
determined by the Lowry assay (BioRad). Proteins transferred to
nitrocellulose membranes were detected with an ECL Western
Blotting Detection System (Amersham) on a ChemiDoc XRS
(BioRad). For analysis, band densities were measured using Image
J (v1.38x, National Institutes of Health freeware; http://rsb.info.
nih.gov/ij), background intensity was subtracted for each individ-
ual lane and normalized to GAPDH or b-actin loading controls.
For quantification, blots within the linear range of detection were
selected by plotting the band density versus exposure time. An
average for each treatment condition was determined with error
bars representing min/max intensities (where n=2) or SEM
(where n=4). Results are presented as a percentage of the mean
control band intensities.
Microscopy
Cells were fixed with 4% paraformaldehyde at 37uC for
35 minutes, permeabilized for 90 sec with 0.05% Triton X-100 in
PBS or ice-cold 80% methanol/20% PBS (16), blocked in 5%
goat serum and immunostained using primary antibodies and
fluorescent secondary antibodies described above. Epifluorescence
images were obtained on a Zeiss Axioplan 2 microscope, captured
with a CCD camera driven by AxioVision software. Single labeled
cells/sections were used to check for bleed-through in all double-
label immunofluorescence studies. Confocal images were obtained
on a Zeiss LSM 510 Meta driven by LSM 510 software. All
captured images were converted to Tagged Image Files for
subsequent analysis and presentation.
Nuclear accumulation analysis
For quantification of cells containing nuclear accumulation of
AT100 label in control, AM- and Lat B-treated conditions, a
number of randomly selected fields on each coverslip were selected
and cells containing nuclear tau were counted and expressed as a
percentage of the total number of counted cells. Inclusion criteria
for nuclear accumulation were (i) general neuron morphology
appeared normal (including intact nucleus) (ii) neuron exhibited
obvious co-localization of AT100 label with DAPI nuclear label
and (iii) nucleus exhibited AT100 fluorescence intensity .1.56the
intensity of nuclei of surrounding, unaffected cells, as measured
using Image J. Over 200 cells were counted for each condition in
duplicate experiments using independently prepared cell cultures.
Human tissue preparation
Post-mortem time to fixation in formalin (for immunofluores-
cence) was 3 h. For immunofluorescence, paraffin sections (6–
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Scientific), rehydrated to distilled water through decreasing
concentrations of ethanol, microwaved in water for 8 min, blocked
with 5% goat serum for one hour and immunostained.
Transmission Electron Microscopy
Primary chick neurons were grown on glass coverslips, treated,
washed with warm PBS and fixed for 30 min with 2.5%
glutaraldehyde (Electron Microscopy Sciences, USA) in 0.1 M
sodium cacodylate buffer (Sigma-Aldrich). Cells were rinsed with
buffer and post-fixed for 30 min in cold 1% osmium tetroxide
(Sigma-Aldrich). Cells were rinsed again and stained for 2 h with
1% uranyl acetate (Sigma-Aldrich), filtered through 0.22 mm Biofil
Syringe filter in 0.05 M sodium acetate (Sigma-Aldrich). To
prepare TEM grids, cells were dehydrated through increasing
concentrations of ethanol (v/v) (50%, 70%, 95% and ultra-dry
100%), then infiltrated with Spurr’s resin in increasing ratios to
100% ethanol (1:1, 2:1 and 3:1). Cells on coverslips were
embedded in 100% Spurr’s resin and cured at 60uC overnight.
To remove coverslips, resin blocks were placed in liquid nitrogen
for ,15 sec, transferred to warm water and carefully removed.
Resin blocks were section using a diamond knife (70 nm) and
placed on 200-mesh copper TEM grids that were subsequently
post-stained for 10 min with uranyl acetate and lead citrate.
Images were acquired with a Phillips CM 120 Biofilter TEM at
120 kV.
Results
Mitochondrial inhibition induces rapid
dephosphorylation at all MAP/tau phosphoepitopes
except for 12E8
In AD neurons, tau is hyperphosphorylated and abnormally
redistributed to NFTs and neuropil threads in cell bodies and
neurites respectively. The mechanisms by which these processes
occur are not fully understood. The aim of this study was to test
the hypothesis that inhibiting mitochondrial function influences
the phosphorylation state and localization of tau protein. Primary
neuronal cultures (prepared from E7 chick tectum) were treated
for 10, 30, 60 or 120 min with the mitochondrial complex III
inhibitor AM which has previously been shown to reduce the level
of ATP in these neurons by 60% within 10 min [20]. Cells were
then lysed or fixed for immunostaining and probed with a battery
of phospho-tau antibodies - AT270, AT8, AT100, S214, AT180,
12E8, S396, S404 or S422 - that have been raised against different
phosphoepitopes on human tau and have analogous correspond-
ing epitopes in chicken tau (Fig. 1A) The 12E8 antibody
recognizes phosphorylated KXGS motifs in the conserved
MTBDs of both tau and other MAPs [14]. Western blot analysis
of lysates revealed that compared to untreated (control) cells, ATP
reduction leads to dephosphorylation of epitopes S396, AT8,
AT270, AT180, S404 and S422 over the 120 min treatment time
when normalized for loading to GAPDH (Fig. 1B, C). Total tau
was observed to decrease transiently before returning to control
levels at 120 min. By contrast, the blots revealed a strong and
sustained signal for the epitopes recognized by the 12E8 antibody
(Fig. 1D, E). Consistent with this, the ratio of 12E8 to total tau
band intensities increased .2-fold by 60 min whereas the AT8 to
total tau ratio declined over the same time frame to near zero
(Fig. 1D). This trend of persistence of the 12E8 epitope signal was
reproducible in a second independent experiment and combined
(n=4), these data reveal a peak increase to 232669% at 60 min
and sustained phosphorylation at 120 min (15564%, p,0.05)
(mean6SEM) (Fig. 1E).
Redistribution of MAP/tau phosphoepitopes to rod-like
or spheroid inclusions in neurites
Next, we conducted immunofluorescence imaging of the same
phosphoepitopes in AM-treated (15 min.) neurons to investigate
distribution patterns of these antibody labels throughout neurons
following mitochondrial inhibition. While some phosphoepitope
labeling remained relatively smoothly distributed throughout
neurites of AM-treated cells, other labels were aggregated into
spheroid inclusions in affected processes (Fig. 2A–J). Cell body
staining intensity, indicative of phosphorylation state, of phos-
phoepitopes AT8, S214 and AT180 was somewhat reduced
(AT8=,30% intensity of control cells after 15 min AM
treatment), but otherwise comparable to control cells with regards
to its smooth distribution. By contrast, AT270, AT100, S396,
S404, S422 and total tau labeling aggregated into spheroids that
were rarely seen in untreated control cells. Overall cell body
staining intensity for some of these epitopes was also found to be
reduced (AT270 ,40% intensity compared to control cells).
Although the 12E8 antibody labeled some spheroids, it predom-
inantly labeled rod-shaped aggregates throughout neurites (Fig. 2F)
which were previously shown to be AC rods [20]. The insets in
Fig. 2 illustrate the appearance of spheroids and rods respectively.
Rod-shaped structures were observed less often with the S404,
S422 and AT270 phosphoepitope labels (Fig. 2A and G, insets). As
shown for AT270 below, these structures only rarely co-localized
with AC which was in contrast to 12E8 label which largely
colocalized with AC rods.
In AM-treated cells, in addition to labeling neuritic inclusions
that co-localized with total tau immunolabeling, AT100 revealed a
redistribution into cell nuclei in a subset of neurons (,36%), as
indicated by colocalization with the nuclear stain DAPI (Fig. 2D,
asterisks), which was never observed for any other tau epitope
(Supplementary Fig. S1). However, further analysis demonstrated
that this nuclear epitope does not represent tau protein as AT100
also labeled nuclei of mouse tau knockout neurons (LSM, ITW
and JRB unpublished observations). Moreover, neither S214
(which shares the serine-214 recognition site of AT100) nor total
tau labels were ever seen to accumulate in nuclei of AM-treated
cells further suggesting this AT100 accumulation to be non-tau
related. Interestingly however, the same nuclear localization of the
AT100 label was seen in post mortem AD tissue (Supplementary
Fig. S1F).
Co-labeling studies of spheroids in AM-treated cells revealed co-
localization of phospho-tau epitopes with total tau (Fig. 3A and
results not shown), suggesting that these observed aggregates in
ATP-depleted cells are comprised of tau phosphorylated at many
sites. By contrast, rod-like structures immunolabeled for the 12E8
epitope did not co-label with other phosphoepitopes (Fig. 3B). We
had previously demonstrated 12E8 label in AC rods [20], which
we confirm here in both Triton X and methanol permeabilized
cells (Fig. 4A and data not shown). We found that the 12E8
labeling of AC rods in AM treated cells was best preserved under
Triton X permeabilization (Fig. 3B) whereas methanol permea-
bilization resulted mostly in spheroid labeling (Fig. 3C). Further,
12E8-labeled AC rods did not co-localize with S396 label (Fig. 3B)
which by contrast only localized to spheroid structures in the same
cells (arrows Fig. 3B). This further documents the distinct and
separate nature of AC rods versus spheroids.
12E8 but not other phosphoepitopes redistributes to AC
rods during mitochondrial inhibition
To further investigate whether other tau epitopes are present in
AC rods, we carried out double-labeling for ADF and a variety of
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20878Figure 1. ATP reduction causes persistent phosphorylation of 12E8 epitope and dephosphorylation at other sites. (A) Epitope map of
tau antibodies in human and chicken brain [38]. Schematic representations of the longest tau isoforms are shown (441 amino acid residues in human
tau, 463 in chicken). The phosphorylation-dependent anti-tau antibodies (AT270, AT8, S214, AT100, AT180, 12E8, S396 S404 and S422) are shown with
their corresponding target residues (S=Serine, T=Threonine). Positions of the various alternatively spliced inserts which give rise to 6 different
isoforms in humans and 5 in chick are shown in blue. Green boxes denote tandem amino acid sequence repeats, which constitute the MTBD. (B)
Representative Western blots of extracts from cell cultures treated in duplicate with 1 mM AM for 10, 30, 60 or 120 min. (C) Quantification of the
Western blots shown in (B) reveal rapid dephosphorylation of AT8, S396 and AT270 epitopes (respectively declining to 1660.03%, 2369% and
4369% of control values; mean %6min/max intensities). By 30 min, phosphorylation at epitope S404 had also markedly declined (25611%) while
epitopes S422 and AT180 exhibited a more moderate decline in phosphorylation (reduced to 5563% and 65620% at 30 min). Total tau was
observed to decrease transiently (4165% at 30 min) before returning to control levels (98619%) at 120 min. All antibodies were probed on fresh
blots and normalized to GAPDH loading control bands. (D) By contrast, phosphorylation of the 12E8 epitope increased markedly. To ascertain a
phosphorylation:total tau ratio, blots probed for 12E8 or AT8 (for comparison) were stripped and reprobed for total tau (polyclonal rabbit antibody).
Whereas the AT8:total tau ratio decreased rapidly, the 12E8:total tau ratio increased at 30 min and peaked at ,200% after 60 min. Error bars in (C and
D) indicate the maximum and minimum intensities. (E) Quantification of persistent phosphorylation at the 12E8 epitope (normalized to GAPDH) was
significant with a peak of .200% at 60 min and sustained phosphorylation (,150%) at 120 min (n=4; *p,0.05). Error bars=SEM.
doi:10.1371/journal.pone.0020878.g001
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were restricted to mouse monoclonal MAP/tau antibodies for
double-labeling studies). AM-treated cells (15 min) were double-
labeled for ADF and AT270 (Fig. 4B), and ADF and AT100
(Fig. 4C, D). AT270 aggregates only occasionally co-localized with
AC rods (Fig. 4B, arrows), whereas AT100 label was never seen to
co-localize with AC rods after either methanol or Triton-X
permeabilization (Fig. 4C, D; arrows). By contrast, as previously
shown, 12E8 frequently co-localized with AC rods (Fig. 4A and
reference [20]), suggesting this epitope to be of prominent
importance in the immediate stages of MAP recruitment to AC
rods.
Ultrastructural EM analysis of AC rods formed in chick neurons
following ATP-reduction (Fig. 5A, B) corroborated previous results
that demonstrated that AC rods are comprised of many individual
parallel filaments arranged into tightly bundled structures [21,41–
Figure 2. Tau epitopes redistribute in neurons during ATP reduction. Cells were treated with 1 mM AM for 15 min, fixed and permeabilized
for 90 sec with 80% methanol or 0.05% Triton-X. Immunostaining was carried out with antibodies against phosphorylated tau epitopes, as indicated.
Staining for total tau and all phospho-epitopes was predominantly smooth and evenly distributed in control cells. Following ATP reduction,
distribution of AT8 (C), S214 (E) and AT180 (I) epitope labels remained relatively smooth, although staining intensity was reduced. By contrast, AT270
(A), S422 (B), AT100 (D), 12E8 (F), S404 (G) and S396 (H) labeled accumulations that were mostly spheroid in shape, but occasionally rod-like, following
ATP-reduction and were frequently observed in tandem arrays along neurites (arrows). Higher magnification insets of controls vs. AM-treated cells are
shown for A, B, F, and G. Correspondingly, some spheroid-like accumulation of total tau (J, arrows) was also evident in neurites of AM-treated cells.
Interestingly, only aggregates labeled with 12E8 (F) consistently showed classic and distinct rod-shaped structure throughout AM-treated cells, which
is better observed at higher magnification (inset in F, arrows). Additionally, ATP reduction led to the redistribution and nuclear-accumulation of
AT100 label (D, arrows), a phenomenon that was observed neither in control cultures stained with AT100, nor in treated cells labeled with any other
MAP/tau phospho-epitope. However, nuclear AT100 label is unlikely to represent tau (see text). Nuclei were labeled with DAPI (blue). While most
epitopes (except for 12E8 – see Fig. 3) appeared identical under methanol and Triton X permeabilization conditions, images in this figure represent a
combination of both protocols. Methanol: (A, B, E, G, J). Triton X: (C, D, F, H, I. Scale bar=20 mm for all images except insets in (A, B, F, and G)=5 mm.
doi:10.1371/journal.pone.0020878.g002
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individually spaced microtubules approximately 24 nm in diameter
(Fig. 5C).
Actin depolymerization mimics effects of mitochondrial
inhibition on 12E8 epitope redistribution but does not
affect the distribution of other phosphoepitopes
Similar to mitochondrial inhibition, we previously demonstrated
that pharmacologically-induced depolymerization of actin induces
the formation of AC rods which subsequently recruit 12E8
epitopes [20]. In order to determine whether actin depolymeriza-
tion induces redistribution of other phosphoepitopes, we treated
primary neurons with Latrunculin B (Lat B) which induces
depolymerization of actin filaments in the absence of ATP
reduction. The formation and co-localization of AC rods with
12E8 label under these conditions was confirmed (not shown). In
contrast to AM-treated cells, staining for other phosphoepitopes
including AT100 (Fig. 6A) and S396 (Supplementary Fig. S1D) in
Lat B treated cells revealed an even distribution along neurites.
Western blot analysis of Lat B-treated neurons revealed a 2.9-fold
increase in 12E8 immunoreactivity after 2 min treatment while
other phosphoepitopes such as S396 remained largely unchanged
(Fig. 6B, C). These results confirm that 12E8 is the primary
epitope recruited to Lat B-induced AC rods during actin
reorganization, as was also found to be the case for AC rods
induced by ATP-reduction. Together these results provide
evidence for an important role of KXGS phosphorylation in the
initial recruitment of tau or other MAPs to AC rods during times
of cellular stress.
Discussion
Disrupted energy metabolism, mitochondrial dysfunction and
increases in oxidative stress in the ageing brain have been linked
with the onset of AD pathologies, including aberrant distribution
and accumulation of hyperphosphorylated tau and deposition of
amyloid-b [24,44–47]. The aim of this study was to investigate
whether induced mitochondrial dysfunction could elicit changes in
tau phosphorylation and distribution in healthy neurons in cell
culture, since mechanisms leading to hyperphosphorylation and
redistribution of tau remain elusive, yet are central to understand-
ing the pathogenesis of AD.
Here, we treated primary neuronal cell cultures derived from
chick tecta with the mitochondrial inhibitor AM that rapidly
depletes cellular ATP [20] and subsequently analyzed changes to
phosphorylation and sub-cellular distribution of tau using Western
blotting and immunolabeling. Whereas dephosphorylation was
observed for every other epitope over 120 min, we observed a
substantial increase in phosphorylation at the 12E8 site, an ‘early
Figure 3. Distinct rod-shaped aggregates are specific to 12E8 and are best preserved with Triton-X permeabilization. ATP-depleted
cells were permeabilized for 90 sec with 80% methanol or 0.05% Triton-X and co-labeled for epitopes of tau. (A) Under both methanol and Triton-X
methods, aggregations containing AT270 epitopes co-labeled with total tau (shown here with methanol permeabilized cells) suggesting spheroid
neuritic aggregates are comprised of tau phosphorylated at numerous epitopes. (B) By contrast, 12E8-labeling was predominantly in distinct rod-
shaped aggregates that did not co-label with other phospho-tau epitopes (shown here for S396). 12E8-positive AC rods were best visualized
following Triton-X permeabilization. (C) Using methanol permeabilization protocols, 12E8 by contrast more often labeled spheroid structures thata s
described above could be co-labeled with many other tau epitopes (shown here for S396). Scale bar=20 mm.
doi:10.1371/journal.pone.0020878.g003
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of human tau [1,14] (Fig. 1). Notably, we previously demonstrated
that this epitope is incorporated into AC rods, which are also
generated under ATP depleting conditions [20] (confirmed here in
Fig. 4A). The MAP protein family, including the vertebrate
proteins tau, MAP2, doublecortin and MAP4 (the latter of which is
non-neuronal) contain homologous conserved ‘KXGS’ repeat
motifs in MTBDs [8,48,49]. In light of this, although tau is
probably the most predominant protein recognized by 12E8, we
cannot completely discount that the 12E8-immunoreactivity we
are observing in AC rods might be due to the presence of other
MAPs in addition to tau.
In animal models of ischemia-reperfusion, rapid dephosphory-
lation of tau occurs during the initial ischemia and we have
confirmed in our primary neuronal cell culture model that tau
dephosphorylation not hyperphosphorylation is the immediate
Figure 4. Recruitment to AC rods during ATP reduction is specific for ‘KXGS’ phosphorylated species. (A) Confirmation of 12E8-positive
MAP/tau in AC rods during ATP reduction [20]. These inclusions often form in tandem arrays along neurites (arrows). Inset shown at higher
magnification in lower panel of (A). Additional double-labeling was performed with AT270 (B) or AT100 (C) and ADF, to see if there was any
relationship between these tau epitopes and AC rods. AC rods only sometimes overlapped with AT270 (B, arrows) and were never observed to co-
localize with AT100, under either Triton-X or methanol permeabilization (C and D, arrows). These results suggest AC rods are distinct from MAP/tau-
containing neuritic spheroids and recruit only the 12E8-phosphorylated MAP/tau isoform into distinct rod structures during ATP reduction. (A, B and
D)=Triton X permeabilized. Scale bar=20 mm; 5 mm (inset in (A)).
doi:10.1371/journal.pone.0020878.g004
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depletion) [50]. An interesting exception to this, consistent in
both cell culture and in an animal model, is the enduring
phosphorylation of the 12E8 epitope that has been reported in a
gerbil-model of brain ischemia [51]. However after reperfusion,
tau proteins are slowly phosphorylated and accumulate, resulting
in hyperphosphorylation days after the initial ischemic event in the
animal potentially due to the down-regulation of phosphatases or
induction of specific kinases, although the mechanism remains to
be determined [50]. Importantly, our cell culture model is
consistent with the animal models and mimics early signaling
events directed to tau during transient brain ischemia. While we
are not saying that such a large scale global ischemic event is
directly relevant to AD, it is interesting that stroke is a significant
risk factor for the later development of dementia and AD [50].
More commonly in AD, smaller less severe microischemic events
Figure 5. Rod-like accumulations in neurites of primary chick neurons contain densely packed filaments. Transmission electron
micrographs of primary chick neurons treated with 1 mM AM for 15 min, fixed and processed for TEM as described in Methods. (A) Densely packed
linear arrays of filaments occur in the neurite (white arrows). The lower panel shows a higher magnification view of the boxed region above. (B)
Another example of densely packed filaments within a neurite (white arrow). Here the filament bundle spans a large proportion of the width of the
neurite. (C) In contrast, unaffected neurites contain individual separated microtubules approximately 24 nm in diameter (black arrows). Scale
bars=0.2 mm.
doi:10.1371/journal.pone.0020878.g005
Changes in Phospho-MAP/Tau during Neuronal Stress
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e20878and highly localized cytopathology could reflect a sub-optimal or
failing local microvasculature [52].
In contrast to 12E8, other phosphoepitopes including AT270,
S422, AT100, S396 and S404 mostly accumulated in small
neuritic spheroid swellings in ATP depleted neurons. We found
these phosphoepitopes only occasionally co-localized with ADF
immunostaining in rod-shaped structures (Fig. 2 and 3), and this
observation was rare compared to the high level of co-localization
of ADF and 12E8 (Fig. 4). We can conclude that recruitment to
AC rods during these conditions is primarily specific to KXGS-
phosphorylated species in the initial stages. The occasional rod-
shaped structure formed by S404 and AT270 label (Fig. 2) and
rare co-localization of AT270 with ADF in AC rods, suggests that
other phosphoepitopes of tau may appear in AC rods later, a
subject of ongoing investigation. In primary neurons, Lat B-
induced actin depolymerization also resulted in specific recruit-
ment of 12E8 epitopes to AC rods, with a concomitant ,3-fold
increase in the signal of the band recognized by 12E8 on
immunoblots following 2 min Lat-B treatment (Fig. 6). By
contrast, S396 was neither seen to redistribute into spheroid or
rod-like aggregates nor deviate from control levels of phosphor-
ylation. These data suggest that actin rearrangement in this cell
model triggered either by changes in cellular ATP levels or directly
by actin depolymerizing drugs may be an upstream effector of
KXGS phosphorylation and redistribution of MAP into AC rods.
Converging or independent signaling mechanisms triggered by
mitochondrial dysfunction, excess glutamate, oxidative stress,
calcium deregulation or other effectors leading to AC rods and
MAP/tau redistribution in vivo are potentially multifold
[22,43,47,53]. Oxidative stress and calcium have previously been
implicated in the cytoskeletal pathology of AD and studies have
shown both calcium-dependent and –independent pathways
leading to AC rods in various model systems [22,43,53]. More
work is needed to delineate the involvement of these pathways in
AD.
A predominant function of tau protein is to bind and stabilize
axonal MTs – the tracks for cargo transport to synaptic terminals.
Hyperphosphorylation of tau in the MTBD by microtubule
affinity regulating kinase (MARK)/PAR1 or other kinases gives
rise to a destabilized MT network and concomitant self-assembly
of the increased concentration of unbound tau [13,15,16]. This
self-assembled tau is purported to serve as a seed for further
assembly of redistributed tau into PHFs along neurites (neuropil
threads) and in the somatodendritic domain (neurofibrillary
tangles) [1,2,54,55]. Albeit in a cell model and not demonstrated
in situ in brain tissue, our results suggest that AC rods may
contribute to the sequestration and accumulation of unbound tau
via its phosphorylated MTBD in neurites leading to neuropil
thread-like inclusions and potentially PHFs. We speculate that
rapid depolymerization and rearrangement of the actin cytoskel-
eton during rod assembly may induce activation of MARK/Par-1
or other kinases, the former of which has previously been
Figure 6. 12E8 but not other tau epitopes aggregates and co-localizes with AC rods during actin depolymerization. Primary chick
neurons were treated with 1 mg/ml Latrunculin B (Lat B) for 15 min, fixed and immunostained. We first confirmed formation of both AC and 12E8-
MAP/tau positive rods in Lat B treated cultures (data not shown), as has previously been observed [20] and then co-stained cultures for ADF with
numerous tau epitopes. Whereas an abundance of AC rods were induced by Lat B (A, arrows), label for all tau epitopes, except 12E8, remained
relatively smooth and evenly distributed throughout neurites, as shown here for AT100 (A) (other epitopes not shown). Western blots of lysates of Lat
B-treated neurons were probed with the same battery of antibodies to tau phospho-epitopes. While most epitopes such as S396 (shown here)
showed little change in phosphorylation during Lat B treatment, the 12E8 epitope was strongly phosphorylated within 2 min of treatment (B, C).
Band intensities were quantified for each time-point for 12E8 and S396 immunoblots (C) with each lane normalized to individual b-actin loading
controls and then calculated as a percentage of control band intensities. At 2 min, 12E8 phosphorylation was 2.960.1-fold higher than control means
(mean 6min/max intensities). Scale bar=10 mm.
doi:10.1371/journal.pone.0020878.g006
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[15,56,57]. Consistent with this, activation of MARK correlates
with elevated phosphorylation and dendritic accumulation of tau
in stressed primary hippocampal neurons [47].
Extensive studies have demonstrated a role for tau and other
MAPs in cross-linking and bundling of actin filaments [28–37].
Some studies have additionally demonstrated that MAP-actin
association is regulated by the reversible phosphorylation of MAPs
and that furthermore, tau and MAP2 interactions with actin occur
via KXGS-containing motifs in the repeat regions of their MTBD
domains [31,32,58]. That 12E8 labeled epitopes co-localized with
AC rods in our study further supports a central role for KXGS
motifs in the rapid association with actin. Moreover, EM analysis
of AC rods following 15 min AM treatment in primary neurons
demonstrate the presence of filamentous bundles (Fig. 5), and we
speculate that AC-actin bundles form initially and serve as
nucleation sites for subsequent recruitment of 12E8 epitopes. A
recent study of human AD brains provides some support for this
notion, which reported a correlation between increased cofilin
expression and tau pathology in specific regions of the brain,
including the temporal cortex [59–61]. Expression of the
microRNA miR-107 has been shown to decrease in AD brain
[60], which is associated with increased amyloid precursor protein
and cofilin protein levels and formation of cofilin rod-like
structures [61]. In regions of AD brains with confirmed reduction
of miR-107 expression, a significant increase in NFTs was
observed when compared with adjacent tissue expressing normal
levels of miR-107 [59].
Further investigations are required to delineate the mechanisms
facilitating the interaction between MAP and AC-actin rods and
whether it is direct or indirect. Important questions that remain to
be answered are whether the KXGS phosphorylation of tau or
other MAPs is causative or correlative with its association with
actin or AC rods and what mechanism facilitates the interaction
between 12E8 epitopes and AC rods. Recent characterization of
isolated AC rods demonstrated the presence of the scaffolding
protein 14-3-3f [42] which was also shown to be associated with
12E8 within AC rods (unpublished observations LSM and JRB),
suggesting that 14-3-3f may have a role either in rod structure or
in a longer time-dependent maturation of MAP/tau phosphory-
lation, as has previously been suggested in other studies [62–64].
Answering these questions is the subject of ongoing studies.
In summary, we have shown that mitochondrial inhibition is
associated with specific and sustained detection of 12E8 epitopes
indicative of MAP phosphorylation in MTBD KXGS motifs, but a
concomitant dephosphorylation of other phospho-tau epitopes.
The combined effects of MT destabilization and accumulation of
MAP/tau and cofilin-actin rods in the neurites is proposed to
inhibit axonal transport, ultimately leading to synaptic pruning
and neuronal death [47,65–68]. The present findings therefore
suggest that targeting disrupted energy metabolism, mitochondrial
dysfunction and downstream actin reorganization in aging cells
may help prevent neurodegeneration associated with aberrant
phosphorylation, redistribution and self-assembly of tau.
Supporting Information
Figure S1 AT100 labels a non-tau component in the nucleus
during mitochondrial inhibition, actin depolymerization and in
postmortem AD brain. Primary chick neurons were treated with
1 mMA Mo r1mg/ml Lat B for 15 min, fixed, immunostained
and analyzed via confocal laser scanning. ATP reduction with AM
induced nuclear accumulation of the AT100 label in a proportion
of neurons (3662%; mean6SEM), as indicated by co-localization
with DAPI (A, B). Co-stainings revealed no obvious translocation
of total tau into the nuclear compartment in cells exhibiting
AT100 nuclear accumulation (B, arrows), suggesting the AT100
antibody is labeling a protein other than tau. AT100 labeling in
untreated cells (C) remained contained in the neurites. Similarly,
actin depolymerization with Lat B gave rise to nuclear
accumulation of AT100 label in 2262% cells (mean6SEM) (D)
and again, lack of total tau and other epitopes such as S396 (D) in
the nucleus. Interestingly, pre-treating cultures for 2 min with the
F-actin stabilizing drug jasplakinolide prevented nuclear accumu-
lation of AT100 in cultures subsequently treated with either AM or
Lat-B (data not shown). Formalin-fixed 7 mm brain sections from
the hippocampal region of confirmed AD cases were immuno-
stained for phospho-tau epitopes. S396 label (E) and other tau
epitopes (data not shown) often accumulated in flame-shaped
tangles, though remained largely absent from the nucleus (E,
arrows). By contrast, double-labeling studies showed AT100 label
frequently appearing in the nuclear compartment as evidenced by
its co-localization with DAPI (F, arrowhead). In the same neurons,
S396 was exclusively contained within the somal compartment (F,
arrow). Although characterization and identification of this
AT100-positive protein is beyond the scope of the present study,
further investigation of this stress-induced response would be
valuable as the appearance of the epitope in the nucleus
specifically occurs in stressed cells (ATP depleted) or AD brain
and not control cells. Images in (A–D): confocal microscope; (E, F):
optical microscope. Scale bars=10 mm (A, F); 20 mm (B–E).
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